B cell lymphoproliferative disorders and VH4-34 gene encoded antibodies

Human Antibodies

Volumn 13, Issue 3, 2004, Pages 63-68

  Bhat, Neelima M ^a   Bieber, Marcia M ^a   Yang, Yuh Cheng ^b   Leu, Yi Shing ^b   Van Vollenhoven, Ronald F ^c   Teng, Nelson N H ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b MACKAY MEMORIAL HOSPITAL   (Taiwan)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

autoantibodies; B cell hyperproliferation; B cell regulation; EBV; lymphotropic viruses; VH4 34 gene

Indexed keywords

ANTIBODY; ANTIBODY VH4 34; IMMUNOGLOBULIN HEAVY CHAIN; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HEPATITIS C; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; INFECTIOUS MONONUCLEOSIS; LYMPHOPROLIFERATIVE DISEASE; MULTIPLE SCLEROSIS; NASOPHARYNX CANCER; NONHUMAN; PRIORITY JOURNAL; SARCOIDOSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; UTERINE CERVIX CARCINOMA;

EID: 12944270254     PISSN: 10932607     EISSN: None     Source Type: Journal    
DOI: 10.3233/hab-2004-13302     Document Type: Article

References (34)

1. V. Pascual and J.D. Capra, VH4-21, a human VH gene segment overrepresented in the autoimmune repertoire, Arthr. Rheum. 35 (1992), 11-18.
2. N.M. Bhat, M.M. Bieber, M.B. Spellerberg, F.K. Stevenson and N.N.H. Teng, Recognition of auto and exoantigens by V4-34 gene encoded antibodies, Scand. J. Immunol. 51 (2000), 134-140.
3. N.P. Weng, J.G. Snyder, L.L. Yu and D.M. Marcus, Polymorphism of human immunoglobulin VH4 germ-line genes, Eur. J. Immunol. 22 (1992), 1075-1082.
4. P. Kraj, D.F. Friedman, F. Stevenson and L.E. Silberstein, Evidence for the overexpression of the VH4-34 (VH4.21) Ig gene segment in the normal adult human peripheral blood B cell repertoire, J. Immunol. 154 (1995), 6406-6420.
5. F.K. Stevenson, G.J. Smith, J. North, T.J. Hamblin and M.J. Glennie, Identification of normal B-cell counterparts of neoplastic cells which secrete cold-agglutinins of anti-i and anti-I specificity, Br. J. Haematol. 72 (1989), 9-15.
6. S. Ciaffoni, R. Luzzati, C. Roata, I.A. Turrin, O. Antonello and G. Aprili, Presence and significance of cold agglutinins in patients with HIV infection, Haematologica 77 (1992), 233-236.
7. C.J. Chapman, M.B. Spellerberg, G.A. Smith, S.J. Carter, T.J. Hamblin and F.K. Stevenson, Autoanti-red cell antibodies synthesized by patients with infectious mononucleosis utilize the VH4-21 gene segment, J. Immunol. 151 (1993), 1051-1061.
8. D. Isenberg, M. Spellerberg, W. Williams, M. Griffiths and F. Stevenson, Identification of the 9G4 idiotope in systemic lupus erythematosus, Br. J. Rheumatol. 32 (1993), 876-882.
9. R.F. van Vollenhoven, M.M. Bieber, M.J. Powell, P.K. Gupta, N.M. Bhat, K.L. Richards, S.A. Albano and N.N.H. Teng, VH4-34 encoded antibodies in SLE: a specific diagnostic marker that correlates with clinical disease characteristics, J. Rheumatol. 26 (1999), 1727-1733.
10. F.K. Stevenson, M. Wrightham, M.J. Glennie, D.B. Jones, A.R. Cattan, T. Feizi, T.J. Hammblin and G.T. Stevenson, Antibodies to shared idiotypes as agents for analysis and therapy for human B cell tumors, Blood 68 (1986), 430-436.
11. K.N. Potter, Y. Li, V. Pascual, R.C.J. Williams, L.C. Byres, M. Spellerberg, F.K. Stevenson and D.J. Capra, Molecular characterization of a cross reactive idiotope on human immunoglobulins utilizing the VH4-21 gene segment, J. Exp. Med. 178 (1993), 1419-1428.
12. I.C. Mockridge, C.J. Chapman, M.B. Spellerberg, D.A. Isenberg and F.A. Stevenson, Use of phage surface expression to analyze regions of a human V4-34 (VH4-21)-encoded IgG autoantibody required for recognition of DNA, J. Immunol. 157 (1996), 2449-2454.
13. W.K. Funkhouser and R.A. Warnke, Preferential IgH V4-34 gene segment usage in particular subtypes of B-cell lymphoma detected by antibody 9G4, Human Pathology 29 (1998), 1317-1321.
14. N.M. Bhat, L.M. Lee, R.F. van Vollenhoven, N.N.H. Teng and M.M. Bieber, V4-34 Encoded Antibody In SLE: Effect Of Isotype, J. Rheumatol. 29 (2002), 2114-2121.
15. E. T. Lennette, Epstein-Barr Virus, in: Manual of Clinical Microbiology, P. Murray, ed., ASM Press, Washington DC, (1995), pp. 905-910.
16. D. Roelcke, Cold agglutination, Transfusion Med. Rev. 2 (1989), 140-166.
17. Y. Xu and P.H. Weirnik, Systemic lupus erythematosus and B-cell hematologic neoplasm, Lupus 10 (2001), 841-850.
18. M.T. McClain, J.B. Harley and J.A. James, The role of Epstein-Barr virus in systemic lupus erythematosus, Front. Biosci. 6 (2001), 137-147.
19. G. Niedobitek, Epstein Barr virus infection in the pathogenesis of nasopharyngeal carcinoma, Mol. Pathology 53 (2000), 248-254.
20. B.D. Walker and G.M. Lauer, Hepatitis C virus infection, New Engl. J. Med. 345 (2001), 41-52.
21. C. Ferri, L. La Civita, A.L. Zignego and G. Pasero, Viruses and cancers: possible role of hepatitis C virus, Eur. J. Clin. Invest. 27 (1997), 711-718.
22. O.P. Sharma, Sarcoidosis and other autoimmune disorders, Curr. Opin. Pulmonary Med. 8 (2002), 452-456.
23. R. Dolcetti and M. Boiocchi, Cellular and molecular basis of B-cell clonal expansions, Clin. Exp. Rheumatol. 14 (1996), 3-13.
24. N.M. Bhat, M.M. Bieber, L.W. Young and N.N.H. Teng, Susceptibility of B cell lymphoma to human antibodies encoded by the V4-34 gene, Crit. Rev. Oncol. Hematol. 39 (2001), 59-68.
25. A.E. Pugh-Bernard, G.J. Silvermann, A.J. Cappione, M.E. Villano, D.H. Ryan, R.A. Insel and I. Sanz, Regulation of inherently autoreactive VH4-34 B cells in the maintainance of human B cell tolerance, J. Clin. Invest. 108 (2001), 1061-1070.
26. G.V. Pinchuk, C.M. Alexander, A.M. Glas, R.J. Armitage and E.C.B. Milner, VH repertoire in human B lymphocytes stimulated by CD40 ligand and IL-4: Evidence for positive and negative selection mechanisms coupled to CD40 activation, Mol. Immunol. 33 (1996), 1369-1376.
27. R.J. Noelle, J.A. Ledbetter and A. Aruffo, CD40 and ligand, an essential ligand-receptor pair for thymus-dependent B cell activation, Immunol. Today 13 (1992), 431-433.
28. I.S. Grewal and R.A. Flavell, CD40 and CD154 in cell-mediated immunity, Ann. Rev. Immunol. 16 (1998), 111-135.
29. J.L. Xu and M.M. Davis, Diversity in the CDR3 region of VH is sufficient for most antibody specificities, Immunity 13 (2000), 37-45.
30. C.A. Michie and J. Cohen, The clinical significance of T-cell superantigens, Trends Microbiol 6 (1998), 61-65.
31. G.J. Silverman, Adoptive transfer of a superantigen induced hole in the repertoire of natural IgM-secreting cells, Cell Immunol 209 (2001), 76-80.
32. K.N. Potter, P. Hobby, S. Klijn, F.K. Stevenson and B.J. Sutton, Evidence for involvement of a hydrophobic patch in framework region 1 of human V4-34 encoded Igs in recognition of the red blood cell I antigen, J. Immunol. 169 (2002), 3777-3782.
33. M. Luppi and G. Torrelli, The new lymphotropic herpesviruses (HHV-6, HHV-7, HHV-8) and hepatitis C virus (HCV) in human lymphoproliferative diseases: an overview, Haematologica 81 (1996), 265-281.
34. D.V. Ablashi, S.F. Josephs, A. Buchbinder, K. Hellman, S. Nakamura, T. Llana, P. Lusso, M. Kaplan, J. Dahlberg and S. Memon, Human B-lymphotropic virus (human herpesvirus-6), J. Virol. Methods 1-4 (1988), 29-48.